FDA fully approves 'novel' Alzheimer’s disease drug Leqembi

The Food and Drug Administration (FDA) has fully approved a “novel” drug used to treat adult patients with Alzheimer’s, the agency announced. Leqembi, which is produced by Japanese drugmaker Eisai and American-based drugmaker Biogen, was initially approved in January under the Accelerated Approval

COVID booster dose for certain people approved by FDA

The Food and Drug Administration announced on Tuesday that older individuals and those with weakened immune systems are eligible for another dose of the updated COVID-19 booster. According to the FDA’s announcement, most people who received a single dose of the booster